Axel Kicillof announced this Monday that the province of Buenos Aires will begin to register for vaccination against the coronavirus “boys and girls between 13 and 17 years old with comorbidities.”
At a press conference, the Buenos Aires president assured that his government will start with the logistics task necessary to start the immunization process for that age group when the respective vaccines are “approved”.
“Today we have two candidate vaccines for those under 18 years of age, not yet approved. Moderna’s Vaccine and Sinopharm’s Vaccine. As of today, we are opening the registration for boys and girls between the ages of 13 and 17, particularly those with comorbidities. We are opening the registration to Vacunate Buenos Aires through the website or the phone App ”, he indicated.
Last Friday, 3,500,000 doses of Moderna arrived in two flights of Aerolineas Argentinas donated by the United States and that will serve to accelerate the immunization plan. These doses are expected to be used for children and adolescents with previous illnesses.
In the case of Sinopharm vaccines, they are already being applied in children under 18 years of age in China, but they have not been approved by the National Administration of Drugs, Food and Medical Technology (Anmat).
“We are starting an enrollment campaign” for girls and boys from 13 to 17 years old. “Enrollment is enabled. We still do not have qualified vaccines, “but” we do have vaccines, “said the Buenos Aires governor.
And he added: “We are preparing ourselves to be able to design the logistics of the vaccine when we already have the approval” by the Anmat. “For us, this is tremendously important”.
Kicillof said that the case of minors “obviously is a population that has less risk”, but clarified that the objective is “start the vaccination process that leads to the vaccination of those who have any disease which makes them a specific risk population with comorbidities ”.
The vaccination of minors with comorbidities is a claim that has multiplied in recent weeks throughout the country. Last Saturday a group of around 200 parents demonstrated in the Plaza de Mayo to demand the urgent immunization of their children in risky conditions.
On that occasion they asked for the urgent application of the Pfizer vaccine since, they argued, it is the only one authorized by the international scientific community for minors between 12 and 17 years of age. However, they said that if Anmat approves Moderna’s vaccine for children and adolescents it will be welcome.